精密瘤学中的脂质体纳米载体:进展和前景
1Hunan Key Laboratory of The Research and Development of Novel Pharmaceutical Preparations, School of Pharmaceutical Science, Changsha Medical University, Changsha, 410219, China.
Critical reviews in oncology/hematology
|March 1, 2026
概括
脂质体,先进的纳米载体,通过改善药物输送和降低毒性来增强癌症治疗. 目前正在进行的研究重点是克服在精密瘤学中一致,针对患者的纳米医学的挑战.
科学领域:
- 纳米医学和瘤学
- 药物输送系统 药物输送系统
- 生物技术是生物技术.
背景情况:
- 脂质体是临床验证的纳米载体在瘤学.
- 脂质组成,制造和功能化的进步提高了脂质细胞的性能.
- 与传统化疗药物相比,脂质体提供了改善的药理动力学和降低的毒性.
研究的目的:
- 审查脂肪体纳米载体在精密瘤学中的演变作用.
- 综合当前的理解,工程策略和临床证据.
- 突出设计原则和纳米药物交付的翻译策略.
主要方法:
- 对脂质体工程和临床应用的当前文献的综述.
- 分析脂质组成,制造和功能化方面的进展.
- 与其他纳米载体系统 (如聚合物纳米粒子和外体) 的比较分析.
主要成果:
- 现代脂质体包含响应性元素和成像剂,用于有针对性的输送和跟踪.
- 已批准的脂质体配方显示了临床益处,如延长血液循环和降低毒性.
- 在瘤异质性,免疫清除和CMC要求方面仍然存在挑战.
结论:
- 脂质体在生物相容性,药物负载和临床可翻译性方面具有明显的优势.
- 需要进行进一步的研究,以解决纳米医药的一致性交付的翻译挑战.
- 未来的方向包括混合设计和患者特定的准确瘤学的方法.
相关概念视频
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Site-Targeted Drug Delivery Systems: Polymeric Carriers
63
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
63
Modified-Release Drug Delivery Systems: Site-Targeted
51
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
51


